SLR OF ECONOMIC EVALUATION FOR TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) IN UK

被引:0
|
作者
Mehta, J. [1 ]
Harrison, O. [2 ]
Barwood, C. [3 ]
Ubi, S. [3 ]
Bertranou, E. [2 ]
Bouhlabel, F. [4 ]
Low, E. [5 ]
Shah, A. [6 ]
Korde, R. [4 ]
Shah, J. [4 ]
Gaugris, S. [3 ]
机构
[1] Karyopharm Therapeut, Lexington, MA USA
[2] FIECON, London, Lon, England
[3] FIECON Ltd, St Albans, Hrt, England
[4] Karyopharm Therapeut, Newton, MA USA
[5] Eric Low Consulting, East Lothian, Scotland
[6] Karyopharm Therapeut, Boston, MA USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCN165
引用
收藏
页码:S51 / S52
页数:2
相关论文
共 50 条
  • [21] Patient-Reported Factors in Treatment Satisfaction in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
    Chari, Ajai
    Romanus, Dorothy
    DasMahapatra, Pronabesh
    Hoole, Michael
    Lowe, Maria
    Curran, Chris
    Campbell, Scott
    Bell, Jill A.
    ONCOLOGIST, 2019, 24 (11): : 1479 - 1487
  • [22] Selinexor in Combination with Pomalidomide and Dexamethasone (SPd) for Treatment of Patients with Relapsed Refractory Multiple Myeloma (RRMM)
    Chen, Christine I.
    Bahlis, Nizar J.
    Gasparetto, Cristina
    Tuchman, Sascha A.
    Lipe, Brea
    Baljevic, Muhamed
    Kotb, Rami
    Sutherland, Heather J.
    Bensinger, William I.
    Sebag, Michael
    LeBlanc, Richard
    Venner, Christopher P.
    Schiller, Gary J.
    Lentzsch, Suzanne
    Callander, Natalie S.
    Rossi, Adriana C.
    Sheehan, Heidi
    Van Domelen, Dane
    Kazuharu, Kai
    Wang, Hongwei
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael G.
    White, Darrell J.
    BLOOD, 2020, 136
  • [23] A single-center treatment sequencing analysis in patients with relapsed/refractory multiple myeloma (RRMM)
    Kumar, Swarup
    Clark, Jackson
    Alvarez-Soto, Alvaro
    El Warrak, Samantha
    Kumar, Shruthi
    Braish, Julie
    Reddy, Aswanth
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S190 - S191
  • [24] Treatment of relapsed or refractory multiple myeloma
    Maiolino, Angelo
    Garnica, Marcia
    LEUKEMIA RESEARCH, 2018, 73 : S3 - S3
  • [25] Treatment of Relapsed/Refractory Multiple Myeloma
    Kastritis, Efstathios
    Palumbo, Antonio
    Dimopoulos, Meletios A.
    SEMINARS IN HEMATOLOGY, 2009, 46 (02) : 143 - 157
  • [26] Treatment of relapsed and refractory multiple myeloma
    Engelhardt, M.
    Graziani, G.
    Javorniczky, R.
    Neubauer, J.
    Koehler, M.
    Herget, G. W.
    Waesch, R.
    ONKOLOGE, 2018, 24 (08): : 613 - 624
  • [27] Treatment of relapsed and refractory multiple myeloma
    Seema Singhal
    Jayesh Mehta
    Current Treatment Options in Oncology, 2003, 4 (3) : 229 - 237
  • [28] Treatment of relapsed and refractory multiple myeloma
    Sonneveld, Pieter
    Broijl, Annemiek
    HAEMATOLOGICA, 2016, 101 (04) : 396 - 406
  • [29] TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Zamagni, E.
    Tacchetti, P.
    Barbato, S.
    Cavo, M.
    HAEMATOLOGICA, 2021, 106 (10) : 215 - 218
  • [30] Treatment of relapsed and refractory multiple myeloma
    Lee, Ji Hyun
    Kim, Sung-Hyun
    BLOOD RESEARCH, 2020, 55 : 43 - 53